BRIEF-CDT Equity Files For Non-Timely 10-K With US SEC

Conduit Pharmaceuticals -30.73% Post

Conduit Pharmaceuticals

CDT

4.08

4.20

-30.73%

+2.94% Post

- CDT Equity Inc CDT.O:

  • CDT EQUITY: FILES FOR NON-TIMELY 10-K WITH US SEC

  • CDT EQUITY: FOR YEAR ENDED DEC 31, 2025, ANTICIPATES NET LOSS WILL INCREASE BY ABOUT $21.3 MILLION

Source text: [ID:n0001493152-26-014626]

Further company coverage: CDT.O